New Delhi: Dr Agarwal’s Eye Hospital Limited (AEHL), a leading eye hospital chain in India, has announced its merger with its parent Dr Agarwal’s Health Care, aiming to simplify its operations and boost shareholder’s growth. Under the terms approved by the company’s board, AEHL’s shareholders will get 23 shares of Dr Agarwal’s Health Care Limited (AHCL) for every 2 shares held.
The merger is expected to be completed by mid-2027, subject to regulatory approvals.
“The merger is an important strategic step in the Group’s journey and will help unlock the full potential of the combined businesses. This long-awaited step towards building a simpler and more efficient group structure reflects our commitment to creating significant value for our stakeholders in the long term. We have been working diligently towards this milestone and, as committed to each of you, remain determined to complete the merger process at the earliest. We firmly believe that the approved swap ratio is fair, balanced, and in the best interests of all stakeholders, laying a strong foundation for the next phase of our growth,” Dr. Adil Agarwal, CEO, Dr. Agarwal’s Health Care Limited, said.
Dr Agarwal’s Eye Hospital recorded a Rs.17.26 crore net profit in Q1FY26 as against Rs.14.11 crore in the corresponding quarter last year, a 22.32% rise. Total sales rose 16.90% to Rs.116.92 crore in Q1FY26 as against Rs.100.02 crore last year.
Dr. Agarwal’s Health Care Limited (AHCL) held its IPO and subsequent listing in January 2025. In its Draft Red Herring Prospectus (DHRP), the company had mentioned a three-year timeline to merge both companies eventually.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Readers should conduct their own research or consult with a qualified financial advisor before making any investment decisions.
